Telix Pharmaceuticals Limited Share Price
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.18 AUD | -3.67% |
|
-5.15% | +26.61% |
| Capitalization | 4.99B 3.57B 3.07B 2.81B 2.68B 4.91B 342B 33.68B 13.03B 163B 13.39B 13.1B 566B | P/E ratio 2026 * |
834x | P/E ratio 2027 * | 92.6x |
|---|---|---|---|---|---|
| Enterprise value | 5.4B 3.86B 3.32B 3.04B 2.9B 5.31B 370B 36.42B 14.09B 176B 14.48B 14.17B 612B | EV / Sales 2026 * |
3.96x | EV / Sales 2027 * | 3.4x |
| Free-Float |
82.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -3.67% | ||
| 1 week | -5.15% | ||
| Current month | -5.47% | ||
| 1 month | -3.93% | ||
| 3 months | +59.68% | ||
| 6 months | +0.85% | ||
| Current year | +26.61% |
| 1 week | 14.22 |  | 14.99 |
| 1 month | 13.94 | | 15.76 |
| Current year | 8.26 | | 15.98 |
| 1 year | 8.26 | | 27.4 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 02/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 30/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 02/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 02/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 18/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.67% | -5.15% | -44.91% | +24.60% | 3.57B | |
| -1.05% | -2.82% | -18.17% | -17.01% | 41.67B | |
| -3.73% | -6.04% | +28.41% | +26.96% | 32.6B | |
| -2.55% | +2.71% | +268.39% | +461.74% | 30.97B | |
| -0.91% | -5.37% | +18.41% | -12.40% | 28.23B | |
| -3.23% | -4.84% | +27.50% | +20.01% | 26.41B | |
| -2.03% | +0.77% | - | - | 14.94B | |
| +6.21% | -2.39% | +176.35% | +4,385.95% | 14.13B | |
| -1.92% | -1.95% | +121.19% | +104.49% | 12.27B | |
| -1.11% | -0.10% | +5.63% | -0.70% | 12.12B | |
| Average | -1.30% | -1.67% | +64.76% | +554.85% | 21.69B | |
| Weighted average by Cap. | -1.55% | -2.14% | +67.40% | +386.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.36B 975M 839M 767M 732M 1.34B 93.5B 9.2B 3.56B 44.39B 3.66B 3.58B 155B | 1.6B 1.14B 983M 899M 858M 1.57B 110B 10.79B 4.17B 52.05B 4.29B 4.2B 181B |
| Net income | 13.01M 9.3M 8M 7.32M 6.98M 12.8M 892M 87.8M 33.98M 424M 34.91M 34.16M 1.48B | 62.54M 44.71M 38.47M 35.18M 33.56M 61.53M 4.29B 422M 163M 2.04B 168M 164M 7.09B |
| Net Debt | 405M 290M 249M 228M 218M 399M 27.8B 2.74B 1.06B 13.2B 1.09B 1.06B 45.98B | 443M 317M 273M 249M 238M 436M 30.41B 2.99B 1.16B 14.44B 1.19B 1.16B 50.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/26 | 14.18 $ | -3.67% | 1,002,141 |
| 15/05/26 | 14.72 $ | -0.88% | 1,123,762 |
| 14/05/26 | 14.85 $ | +2.27% | 1,183,665 |
| 13/05/26 | 14.52 $ | +0.62% | 961,723 |
| 12/05/26 | 14.43 $ | -3.48% | 1,117,758 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition